Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Trends in incidence and survival of early-stage pancreatic ductal adenocarcinoma in the United States.
Authors
Gerardo Perrotta
Cedars-Sinai Medical Center, Los Angeles, CA
Gerardo Perrotta , Yazan Abboud , Arsen Osipov , Ghada Mohamed , Mohamad El Helou , Stephen Jacob Pandol , Simon K. Lo , Srinivas Gaddam
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 633)
DOI
10.1200/JCO.2024.42.3_suppl.633
Abstract #
633
Poster Bd #
K2
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
A multi-institutional study of the impact of the COVID-19 pandemic on pancreatic cancer diagnosis and management.
First Author: Claudia Rosso
Poster
2020 Gastrointestinal Cancers Symposium
Incidence and survival patterns of pancreatic neuroendocrine tumors over the last two decades: A SEER database analysis.
First Author: Mohamad Bassam Sonbol
Poster
2024 ASCO Annual Meeting
Phase 2 randomized study of rintatolimod following FOLFIRINOX in patients with locally advanced pancreatic adenocarcinoma.
First Author: Kelsey Klute
Poster
2024 ASCO Annual Meeting
Real-world ctDNA testing patterns, associated biomarkers and sites of metastasis in early stage colorectal cancer.
First Author: Erin Fidyk